These findings may have translational relevance to human hypertensive heart disease, where dysregulation of RAGE and Rap1a signaling contributes to ventricular hypertrophy and interstitial fibrosis, highlighting these pathways as potential therapeutic targets. This evidence concerns the gene RAP1A and cardiac hypertrophy.